Blonanserin, ≥ 99% Purity. CAS No. 132810-10-7

Bunanserin is a product suitable for the mental domain. Its mechanism of action is different from that of the first-generation (typical) mental domain products, mainly involving the antagonism of the dopamine D2 receptor and the 5-hydroxytryptamine 5-HT2A receptor. This dual effect is believed to have certain advantages in improving positive symptoms (such as hallucinations and delusions) and negative symptoms (such as emotional apathy and social withdrawal) in the mental domain, as well as reducing the incidence of extrapyramidal side effects.

Description

Product name Blonanserin
Other name 2-(4-Ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine; 2-(4-ethylpiperazin-1-yl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine
CAS No. 132810-10-7
Molecular formula C23H30FN3
Molecular weight 367.503
Purity 99%
Appearance white crystalline powder
Packing 1kg/bag, 25kg/barrel
Application Dietary Supplement Raw Material

Product Introduction

The mechanism of action of Bunaneculin differs from that of the first-generation (typical) products, mainly involving the antagonism of dopamine D2 receptors and serotonin 5-HT2A receptors.

Feature

High-purity (≥99%) products are mainly used for research purposes. The powder should be protected from light and repeated freeze-thaw cycles.